The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis

Table 2

Demographic and laboratory results of the euthyroid Hashimoto patients and the control group.

	Euthyroid Hashimoto	Control
Age; (mean ± SD)	36.3 ± 8.11	35.42 ± 7.64	0.49
TSH (mIU/mL)	2.39; [IQR: 1.66–3.13]	1.88; [IQR: 1.46–2.50]	0.06
FT3 (ng/dL)	3.19 ± 0.2	3.32 ± 0.43	0.13
FT4 (ng/dL)	1.17; [IQR: 1.07–1.23]	1.20; [IQR: 1.13–1.34]	0.08
Total-C (mg/dL)	183.6 ± 31.5	176.4 ± 13.6	0.04
TG (mg/dL)	98.5; [IQR: 76.7–140.7]	81.50; [IQR: 69.7–110.75]	0.05
HDL-C (mg/dL)	56.69 ± 11.66	54.68 ± 10.96	0.32
LDL-C (mg/dL)	116; [IQR: 102–136.7]	108.5; [IQR: 97.75–117]	0.01
Lp(a) (mg/dL)	17.85; [IQR: 15.5–38.20]	17.45; [IQR: 10.95–22.02]	0.94
Excess Lp(a) percent (%)	(28%)	: 6 (12%)	0.03
BMI (kg/m^2)	25.58 ± 2.72	24.9 ± 2.52	0.19
HOMA	1.73 ± 0.55	1.59 ± 0.62	0.22

Normally distributed values are indicated as mean ± SD; nonnormaly distributed values are indicated as median and interquartile ranges.
TSH: thyroid stimulating hormone, FT4: free thyroxin, Total-C: total cholesterol, TG: triglyceride, HDL: high density lipoprotein, LDL: low density lipoprotein, Lp(a): lipoprotein(a), and BMI: body mass index; HOMA for insulin resistance index.
values are the differences of euthyroid Hashimoto group and control group.